CUAMC
HZNP

China Universal Asset Management Company’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

China Universal Asset Management Company’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,880
Closed -$680K – 503
2023
Q3 		$680K Buy
5,880
+2,884
+96% +$310K 0.2% 95
2023
Q2 		$308K Sell
2,996
-98
-3% -$10.3K 0.1% 118
2023
Q1 		$338K Buy
3,094
+792
+34% +$87.5K 0.11% 102
2022
Q4 		$262K Buy
2,302
+145
+7% +$12K 0.11% 98
2022
Q3 		$133K Buy
+2,157
New +$151K 0.06% 102

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

China Universal Asset Management Company's HZNP Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 5,880 shares — an estimated $680K sold.

China Universal Asset Management Company first reported a position in HZNP in Q3 2022 and held it in 5 quarters. The position peaked at $680K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • China Universal Asset Management Company reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • China Universal Asset Management Company sold 5,880 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $680K.
  • China Universal Asset Management Company first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022 and held it in 5 quarters.
  • China Universal Asset Management Company's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $680K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.